Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Stem Cell Structure to Facilitate In Vitro Embryonic Studies

By LabMedica International staff writers
Posted on 16 Mar 2017
A biological construct that combines mouse embryonic stem cells and extra-embryonic trophoblast stem cells in a three-dimensional scaffold will allow in vitro studies of cellular interaction in a model that mimics a developing embryo.

The development of a mammalian embryo requires intricate interactions between embryonic and extra-embryonic tissues to orchestrate and coordinate cellular differentiation with changes in developmental potential. More...
In order to develop a model system to facilitate the study of embryonic development in vitro, investigators at the University of Cambridge combined genetically modified mouse embryonic stem cells (ESCs) and extra-embryonic trophoblast stem cells (TSCs) with specific inhibitors in a three-dimensional extracellular matrix scaffold.

The objective was to generate a structure that would that would mimic natural early stage embryos in which the ESCs cluster together at one end of the blastocyst. TSCs, which will form the placenta, are also found within the natural blastocyst as are primitive endoderm stem cells that will form the yolk sac.

The investigators reported in the March 2, 2017, online edition of the journal Science they were able to grow a structure capable of self-assembly whose development and architecture very closely resembled the natural embryo. Development of the embryo-like structure depended on molecular crosstalk involving Nodal signaling.

"Both the embryonic and extra-embryonic cells start to talk to each other and become organized into a structure that looks like and behaves like an embryo," said senior author Dr. Magdalena Zernicka-Goetz professor of physiology, development, and neuroscience, at the University of Cambridge. "It has anatomically correct regions that develop in the right place and at the right time."

"We knew that interactions between the different types of stem cell are important for development, but the striking thing that our new work illustrates is that this is a real partnership - these cells truly guide each other," said Dr. Zernicka-Goetz. "Without this partnership, the correct development of shape and form and the timely activity of key biological mechanisms do not take place properly. We think that it will be possible to mimic a lot of the developmental events occurring before 14 days using human embryonic and extra-embryonic stem cells using a similar approach to our technique using mouse stem cells. We are very optimistic that this will allow us to study key events of this critical stage of human development without actually having to work on embryos. Knowing how development normally occurs will allow us to understand why it so often goes wrong."


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.